Filing Details
- Accession Number:
- 0000899243-18-018341
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-27 16:36:21
- Reporting Period:
- 2018-06-25
- Accepted Time:
- 2018-06-27 16:36:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1707715 | David Scadden | C/O Magenta Therapeutics, Inc. 50 Hampshire Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-25 | 28,076 | $0.00 | 221,575 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2018-06-25 | 6,600 | $15.00 | 228,175 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2018-06-25 | 50,025 | $0.00 | 19,360 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2018-06-25 | 6,429 | $0.00 | 2,488 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2018-06-25 | 16,094 | $0.00 | 6,228 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 580,499 | Indirect | By the Scadden 2016 Family Trust |
Footnotes
- The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date.
- Reflects shares that were purchased through a directed share program in connection with the Issuer's initial public offering.
Billionaire Hedge Funds
